Please login to the form below

Not currently logged in
Email:
Password:

red kite to merge into MSI Consultancy

Healthcare consultancy firm, red kite consultancy group is to become part of MSI Consultancy following the acquisition of red kite by Cello Group – a global marketing group whose members include MSI

red kite consulting group is to become part of MSI Consultancy following the acquisition of red kite by Cello Group – a global marketing group with a focus on the pharmaceutical and healthcare sectors, whose members include MSI.

The merger brings together two specialist healthcare consultancy firms, forming a combined team of 20 employees offering various consulting, research and strategy services across the healthcare and pharmaceutical industries.

The newly formed group will be jointly headed by Jon Bircher, managing partner with MSI, and Jonathan Dancer, manager director with red kite.

Dancer emphasised the benefits of the merger for existing red kit clients: "We are really excited to be working with our colleagues from MSI as part of a larger business with global reach and tremendous range. Current clients of both organisations will be able to access a wider diversity of consulting talent, offerings and services, delivered by project teams that draw on an even wider base of expertise."

Bircher commented on the merger 's effect on the future of MSI: "The coming together of these two complementary businesses is another important step towards our mid-term growth plans to double the size of the team and triple our revenues over the next three years."

11th April 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

Cutting through the noise
AstraZeneca looks to lead an R&D revolution as the company invests in CRISPR and functional genomics drug discovery...
International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...

Infographics